These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Retrospective SPECT/CT dosimetry following transarterial radioembolization. Thompson BC; Dezarn WA J Appl Clin Med Phys; 2021 Apr; 22(4):143-150. PubMed ID: 33710776 [TBL] [Abstract][Full Text] [Related]
9. Use of dose-volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres. Coskun N; Kartal MO; Kartal AS; Cayhan V; Ozdemir M; Canyigit M; Ozdemir E Ann Nucl Med; 2024 Jul; 38(7):525-533. PubMed ID: 38647875 [TBL] [Abstract][Full Text] [Related]
10. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study. Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133 [TBL] [Abstract][Full Text] [Related]
11. Radioembolization of hepatocarcinoma with Chiesa C; Mira M; Bhoori S; Bormolini G; Maccauro M; Spreafico C; Cascella T; Cavallo A; De Nile MC; Mazzaglia S; Capozza A; Tagliabue G; Brusa A; Marchianò A; Seregni E; Mazzaferro V Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3018-3032. PubMed ID: 32451604 [TBL] [Abstract][Full Text] [Related]
12. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387 [TBL] [Abstract][Full Text] [Related]
13. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. Teyateeti A; Mahvash A; Long J; Abdelsalam M; Avritscher R; Kaseb A; Odisio B; Ravizzini G; Surasi D; Teyateeti A; Macapinlac H; Kappadath SC World J Gastroenterol; 2021 Dec; 27(47):8166-8181. PubMed ID: 35068861 [TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of Kappadath SC; Henry EC; Lopez BP; Mahvash A Med Phys; 2024 Sep; 51(9):6061-6074. PubMed ID: 38781554 [TBL] [Abstract][Full Text] [Related]
15. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503 [TBL] [Abstract][Full Text] [Related]
16. 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates. Brosch J; Gosewisch A; Kaiser L; Seidensticker M; Ricke J; Zellmer J; Bartenstein P; Ziegler S; Ilhan H; Todica A; Böning G Phys Med; 2020 Dec; 80():317-326. PubMed ID: 33248338 [TBL] [Abstract][Full Text] [Related]
17. High quality imaging and dosimetry for yttrium-90 ( Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of results after 112 radioembolizations with Casáns-Tormo I; Guijarro-Rosaleny J; Lluch-García P; Rodríguez-Parra H; Roselló-Keränen S; Asensio-Valero L Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(4):255-264. PubMed ID: 37269983 [TBL] [Abstract][Full Text] [Related]
19. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma. Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792 [TBL] [Abstract][Full Text] [Related]
20. Determination of Radiation Absorbed Dose to Primary Liver Tumors and Normal Liver Tissue Using Post-Radioembolization (90)Y PET. Srinivas SM; Natarajan N; Kuroiwa J; Gallagher S; Nasr E; Shah SN; DiFilippo FP; Obuchowski N; Bazerbashi B; Yu N; McLennan G Front Oncol; 2014; 4():255. PubMed ID: 25353006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]